ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,181Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 71

$683K Total Retail Price of All Prescriptions

Rank: 21 out of 71

284 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

47% of this provider’s 284 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

12% of this provider’s 284 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 13,910 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 30.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 785 722 1 1
CITALOPRAM HBR 667 604 2 12
WARFARIN SODIUM 595 593 3 7
LEVOTHYROXINE SODIUM 589 520 4 2
OMEPRAZOLE 500 454 5 3
POTASSIUM CHLORIDE 432 407 6 11
MIRTAZAPINE 407 377 7 15
DONEPEZIL HCL 363 363 8 10
NAMENDA 302 302 9 14
AMLODIPINE BESYLATE 295 254 10 4
METOPROLOL TARTRATE 290 260 11 8
OXYCODONE HCL 260 226 S2 12 54
SIMVASTATIN 242 236 13 5
RISPERIDONE 212 204 14 24
IPRATROPIUM-ALBUTEROL 202 196 15 60
OXYCODONE-ACETAMINOPHEN 177 169 S2 16 51
LAMOTRIGINE 177 148 16 64
GABAPENTIN 169 138 18 13
METOPROLOL SUCCINATE 162 153 19 16
ZOLPIDEM TARTRATE 151 130 20 26
LANTUS 146 131 21 29
HYDROCODONE-ACETAMINOPHEN 143 135 S3 22 9
FAMOTIDINE 142 137 23 78
PERMETHRIN 140 136 24 189
CYMBALTA 132 129 25 31
QUETIAPINE FUMARATE 126 116 26 38
LISINOPRIL 124 105 27 6
POLYETHYLENE GLYCOL 3350 122 121 28 27
NYSTATIN 117 115 29 97
RANITIDINE HCL 117 111 29 36
CEPHALEXIN 112 105 31 87
NOVOLOG 112 96 31 45
DOXYCYCLINE HYCLATE 110 98 33 93
PREDNISONE 106 105 34 36
DIVALPROEX SODIUM 104 104 35 33
PANTOPRAZOLE SODIUM 103 86 36 40
TRAZODONE HCL 101 97 37 23
LOSARTAN POTASSIUM 96 96 38 21
ISOSORBIDE MONONITRATE ER 95 91 39 44
CARBIDOPA-LEVODOPA 95 95 39 66
RESTASIS 95 85 39 157
CARVEDILOL 95 77 39 25
ALLOPURINOL 93 92 43 41
OLANZAPINE 92 92 44 65
LEVOFLOXACIN 92 87 44 63
TAMIFLU 89 82 46 192
VENLAFAXINE HCL ER 85 46 47 82
FENTANYL 81 76 S2 48 68
TRAMADOL HCL 79 77 49 22
AZITHROMYCIN 78 75 50 53
HYDROCHLOROTHIAZIDE 77 75 51 19
ESCITALOPRAM OXALATE 71 69 52 46
NOVOLIN R 69 69 53 75
DIGOXIN 68 67 54 56
SPIRONOLACTONE 65 55 55 58
MORPHINE SULFATE 62 51 S2 56 162
RAMIPRIL 61 61 57 105
MUPIROCIN 61 44 57 126
GENTAMICIN SULFATE 59 53 59 167
BACLOFEN 56 34 60 67
ATORVASTATIN CALCIUM 54 40 61 20
PRAVASTATIN SODIUM 52 52 62 28
LATANOPROST 52 52 62 114
NYSTOP 51 51 64 193
PHENYTOIN SODIUM EXTENDED 51 39 64 83
STROMECTOL 50 48 66 313
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.